At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Phase Contrast Magnetic Resonance in Regurgitant Valvular Heart Diseases
In Brief
An observational study for Valvular Heart Disease (Aortic and Mitral Valves). Completed, enrolled 35 participants across 1 site.
Detailed Summary
The ability to quantify flow directly using through-plane phase contrast velocity mapping is a unique advantage of cardiovascular magnetic resonance and does not rely on the calculation from complex equations as echocardiography. The aim s is to study the role of cardiac MRI in the evaluation of valvular heart disease through quantification of the impact of valvular lesions upon cardiac function by accurate estimation of the left ventricular ejection fraction
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
Primary CompletionJun 2018
Study CompletionJul 2018
First PostedSep 2018
TodayJul 2026
First PostedSep 13, 2018
Enrollment StartJul 1, 2017
Primary CompletionJun 30, 2018
Study CompletionJul 30, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.8 years ago